Researchers have found in a new study that Prophylactic use of tamsulosin did not significantly lower the incidence of ...

The main culprit for increased UTIs in menopausal women is the drop in estrogen levels. Estrogen plays a crucial role in ...

One of the most effective ways to prevent recurrent UTIs in postmenopausal women is vaginal estrogen therapy, which delivers ...

The global portable ultrasound bladder scanner market is projected to grow from USD 144.1 million in 2025 to USD 194.2 ...

Indian men over 50 face rising health risks like prostate issues and hormonal changes. Dr. Manohar shares key signs, ...

Frequent trips to the bathroom can be an early warning sign of an enlarged prostate, also known as Benign Prostatic ...

The Food and Drug Administration said approved UroGen Pharma’s (URGN) Zusduri for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The agency pointed out ...

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

Recurrent urinary tract infections and potentially abnormal Pap smears are among the consequences of untreated GSM.

The FDA approved mitomycin intravesical solution (Zusduri) as a nonsurgical option for recurrent low-grade, intermediate-risk ...

This important study investigates frequency-dependent effects of transcutaneous tibial nerve stimulation (TTNS) on bladder function in healthy humans and, through a computational model, shows that low ...

Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions ...